Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Cardiometrics/Cordis

This article was originally published in The Gray Sheet

Executive Summary

Cardiometrics/Cordis: Ink distribution agreement under which Johnson & Johnson subsidiary Cordis gains U.S. distribution rights to Cardiometrics' FloWire doppler guide wire. The pact broadens an existing agreement for marketing of the device overseas. Cardiometrics says J&J's "strong distribution channels should enable faster market penetration" in the U.S. Under the deal, J&J also gains U.S. rights to Cardiometrics' WaveWire pressure guide wire products. Cardiometrics submitted a 510(k) for WaveWire in December 1996. Cardiometrics, which recently entered an agreement to be acquired by intravascular ultrasound catheter firm EndoSonics ("The Gray Sheet" Feb. 3, p. 9), will continue to market its FloWire and WaveWire products domestically to "40 key accounts" through the end of 1997. At year-end, J&J, EndoSonics, and Cardiometrics will negotiate terms for 1998...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel